Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities:
Net Income (Loss)	$ 187,303	$ 23,878
Non-cash elements included in net income:
Depreciation, depletion and amortization	126,463	149,265
Inventory adjustments	2,421	10,074
Fair value adjustments, net	(30,867)	(6,804)
Provision for reclamation and closure costs	5,801	5,428
Stock-based compensation	7,562	6,401
Deferred income taxes	84,011	14,261
Net foreign exchange loss (gain)	3,568	(3,409)
Other non-cash items, net	2,980	14,609
Change in assets and liabilities:
Accounts receivable	(71,427)	(24,199)
Inventories	(9,048)	(27,375)
Other current and non-current assets	21,693	353
Accounts payable, accrued and other current liabilities	(4,336)	(6,991)
Accrued payroll and related benefits	11,201	6,592
Accrued taxes	11,630	1,069
Accrued reclamation and closure costs and other non-current liabilities	(3,372)	(12,345)
Net cash provided by operating activities	345,583	150,807
Investing activities:
Additions to property, plants, equipment and mine development	(170,043)	(153,708)
Proceeds from investment sales	3,696	0
Proceeds from disposition of assets	714	1,473
Investment purchases	0	(73)
Net cash used in investing activities	(165,633)	(152,308)
Financing activities:
Proceeds from sale of common stock, net	216,225	58,368
Acquisition of treasury stock	(885)	(1,197)
Borrowing of debt	153,000	150,000
Repayment of debt	(427,245)	(265,000)
Dividends paid to common and preferred stockholders	(7,676)	(16,691)
Repayments of finance leases and other	(6,643)	(7,841)
Net cash used in financing activities	(73,224)	(82,361)
Effect of exchange rates on cash	311	(220)
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents	107,037	(84,082)
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period	28,045	107,539
Cash, cash equivalents and restricted cash and cash equivalents at end of period	135,082	23,457
Reconciliation of cash and cash equivalents and restricted cash and cash equivalents above
Cash and cash equivalents	133,910	22,273
Non-current restricted cash and cash equivalents	1,172	1,184
Total cash and cash equivalents and restricted cash and cash equivalents as reported on the consolidated cash flow statement	135,082	23,457
Supplemental disclosure of cash flow information:
Cash paid for interest	43,238	44,424
Cash paid for income and mining taxes, net	7,419	5,730
Significant non-cash investing and financing activities:
Addition of finance lease obligations and right-of-use assets	630	0
Common stock issued as incentive compensation	2,503	4,425
Common stock issued to directors	1,034	770
Common stock issued to interim CEO	0	182
Common stock issued for 401(k) match	$ 3,808	$ 3,714